KINTOR PHARMACEUTICAL LTD.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0529 USD
−21.67 M USD
697.59 K USD
412.46 M
About Kintor Pharmaceutical Ltd
Sector
Industry
CEO
You Zhi Tong
Website
Headquarters
Suzhou
Founded
2009
IPO date
May 22, 2020
Identifiers
3
ISIN KYG5273B1077
Kintor Pharmaceutical Ltd. is a clinical-stage novel drug developer in China, which engages in the proprietary research and development of innovative medicine products for cancers and other Androgen receptor-related diseases. Its business includes product pipeline, R&D platform, and business development. The company was founded by Youzhi Tong and Chuangxing Guo on March 24, 2009, and is headquartered in Suzhou, China.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KNTPF is 0.3316 USD — it has decreased by −5.05% in the past 24 hours. Watch KINTOR PHARMACEUTICAL LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange KINTOR PHARMACEUTICAL LTD. stocks are traded under the ticker KNTPF.
KNTPF stock has fallen by −5.05% compared to the previous week, the month change is a 22.88% rise, over the last year KINTOR PHARMACEUTICAL LTD. has showed a 107.25% increase.
KNTPF reached its all-time high on Nov 24, 2021 with the price of 11.8000 USD, and its all-time low was 0.0835 USD and was reached on Aug 13, 2024. View more price dynamics on KNTPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KNTPF stock is 5.32% volatile and has beta coefficient of 1.62. Track KINTOR PHARMACEUTICAL LTD. stock price on the chart and check out the list of the most volatile stocks — is KINTOR PHARMACEUTICAL LTD. there?
Today KINTOR PHARMACEUTICAL LTD. has the market capitalization of 176.10 M, it has decreased by −6.99% over the last week.
Yes, you can track KINTOR PHARMACEUTICAL LTD. financials in yearly and quarterly reports right on TradingView.
KINTOR PHARMACEUTICAL LTD. is going to release the next earnings report on Mar 26, 2026. Keep track of upcoming events with our Earnings Calendar.
KNTPF net income for the last half-year is −11.39 M USD, while the previous report showed −11.70 M USD of net income which accounts for 2.63% change. Track more KINTOR PHARMACEUTICAL LTD. financial stats to get the full picture.
No, KNTPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 168 employees. See our rating of the largest employees — is KINTOR PHARMACEUTICAL LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KINTOR PHARMACEUTICAL LTD. EBITDA is −21.92 M USD, and current EBITDA margin is −3.10 K%. See more stats in KINTOR PHARMACEUTICAL LTD. financial statements.
Like other stocks, KNTPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KINTOR PHARMACEUTICAL LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KINTOR PHARMACEUTICAL LTD. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KINTOR PHARMACEUTICAL LTD. stock shows the buy signal. See more of KINTOR PHARMACEUTICAL LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.